Will continue to focus on growing business faster than market: Sun Pharma

The company's strategy of developing the Specialty business as an additional growth engine has started delivering, with a gradual ramp up in specialty revenues, Shanghvi said

Drug major Sun Pharma will remain focussed on growing its businesses faster than the market in which it operates, the company said in its Annual Report 2019-20.

Supply chain protection, ensuring optimum utilisation of the factories and working closely with vendors to ensure continuity of supply will be the key focus areas of the company going forward, it added.

"We will continue to focus on growing each of our businesses faster than the market in which we operate. R&D investments in developing a differentiated generic pipeline as well as in building our Specialty pipeline will continue in the coming years,"